Suppr超能文献

少突胶质细胞缺乏髓鞘蛋白 CMTM5 时的进行性轴突病。

Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5.

机构信息

Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Electron Microscopy Core Unit, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

出版信息

Elife. 2022 Mar 11;11:e75523. doi: 10.7554/eLife.75523.

Abstract

Oligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here, we find that expression of the tetraspan-transmembrane protein CMTM5 (chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and central nervous system (CNS) myelin. Genetic disruption of the gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial deficiency causes an early-onset progressive axonopathy, which we also observe in global and tamoxifen-induced oligodendroglial mutants. Presence of the mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.

摘要

少突胶质细胞促进其髓鞘化的轴突的快速冲动传递,并支持其长期完整性。然而,许多髓鞘蛋白的功能相关性仍然未知。在这里,我们发现四跨膜蛋白 CMTM5(趋化因子样因子样 MARVEL 跨膜结构域包含蛋白 5)的表达在少突胶质细胞和中枢神经系统(CNS)髓鞘中高度富集。在小鼠的少突胶质细胞中敲除 基因不会损害 CNS 髓鞘的发育或超微结构。然而,少突胶质细胞缺失导致早发性进行性轴突病,我们也在全局和他莫昔芬诱导的少突胶质细胞 突变体中观察到这种情况。存在 突变可改善轴突病,表明存在 Wallerian 变性样发病机制。这些结果表明 CMTM5 参与少突胶质细胞的功能以维持轴突完整性,而不是髓鞘发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a4/8916772/0a3c4a1e983f/elife-75523-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验